Anti-allergy medicine EpiPen recall expands to US

- A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.

The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing.

Mylan didn't immediately respond to a question about how many devices are affected by the recall. The U.S. Food and Drug Administration says the recall covers 13 lots distributed from December 2015 through July 2016.

The problems could be potentially life-threatening, although Mylan described the incidence of the defects as "extremely rare."

The EpiPen is used to treat allergic reactions to certain food and bug bites.

Click here for a list of the affected lot numbers.

The products can be replaced at no charge by calling 877-650-3494 or emailing customer.service@mylan.com.

Up Next:


Up Next

  • Anti-allergy medicine EpiPen recall expands to US
  • Eclipse deals and specials
  • Find out of you get cash in 'free cruise' robocall settment
  • Florida-based inventors make ZenCrate for anxious dogs
  • Scammers are bombarding Americans with robocalls
  • MoviePass offering unlimited plan to watch new movies in theaters for $10 a month
  • You may be owed money if you received a robocall about a free cruise
  • Coconut oil craze: Flash in the pan, or versatile tool?
  • Reese's Peanut Butter Cup creamer to hit stores soon
  • Starbucks Pumpkin Spice Latte coming to store shelves